Navigation Links
RIKEN and leading Indian institutions launch Joint Research Centers
Date:9/16/2013

RIKEN, Japan's largest research organization launches today two virtual Joint Research Centers with India's premier institution the National Center for Biological Sciences (NCBS), the Jawaharlal Nehru Center for Advanced Scientific research (JNCASR) and the Indian Institute of Science (IISc).

The two centers will facilitate scientific exchange and foster collaborations between Japan and India, in the fields of biology, life science and materials science. They further extend a long history of collaboration between India and Japan, two powerhouses of Asian research and innovation. The new initiative will encompass new areas of research and establish distinctive areas of cooperation.

RIKEN President, Professor NOYORI Ryoji is in India this week to sign the documents that will formally launch the RIKEN- NCBS Joint Research Center; and the RIKEN-JNCASR-IISc Joint Research Center.

On September 14th, 2013 in Delhi, Prof. NOYORI, will sign Memoranda of Understanding (MOUs) between RIKEN and Dr. Ramasami, Secretary, Department of Science and Technology and Dr. Vijay Raghavan, Secretary, Department of Biotechnology, Government of India. Prof. NOYORI will give a lecture to celebrate the signing.

September 16th 2013 will mark the signing of MoU in Bangalore. The signing ceremony at NCBS is to be presided over by Prof. Mayor, Director, on behalf of NCBS and Prof. NOYORI for RIKEN. The signing ceremony at IISc and JNCASR will be carried out by Prof. Rao from JNCASR, Dr. Balaram from IISc, and Prof. NOYORI from RIKEN.

A series of scientific talks by Prof. NOYORI and renowned scientists from RIKEN, and NCBS and inSTEM will mark the commencement of the future collaborations.

The RIKEN-JNCASR-IISc Joint Research Center will support collaboration and facilitate the exchange of research scientists and students working in the fields of materials science and life science research, between the three institutions.

The RIKEN-NCBS Joint Research Center, with the aim to enrich cooperation, will initially focus on supporting the exchange of research staff, postdoctoral researchers and doctoral students working in the areas of biological sciences between RIKEN and NCBS and its allied institutions the Institute of Stem Cell Biology and Regenerative Medicine (inSTEM) and the Center for Cellular and Molecular Platforms (CCAMP). This development builds on long-standing collaborations between researchers at NCBS and the RIKEN Center for Developmental Biology.

RIKEN is Japan's leading multidisciplinary research organization for basic and applied research.

The National Center for Biological Sciences (NCBS) conducts fundamental research in frontier areas of biology.

The Institute of Stem cell biology and Regenerative Medicine (inSTEM) is a state-of-the-art research institute, dedicated to the study of stem cell and regenerative biology.

The Center for cellular and Molecular platforms (CCAMP) acts as an enabler of bioscience research and entrepreneurship by providing research, development, training and service in state of the art technology platforms.

The Jawaharlal Nehru Center for Advanced Scientific research (JNCASR) is a multidisciplinary research institute focusing on research and training at the frontiers of science and engineering.

The Indian Institute of Science (IISc) is India's leading research institute and university for the sciences and engineering.


'/>"/>

Contact: Juliette Savin
pr@riken.jp
RIKEN
Source:Eurekalert

Related biology news :

1. RIKEN and Fujitsu complete operational testing of the K computer
2. Leading evolutionary scientist to discuss how genome of bacteria has evolved
3. Worlds leading coral experts to gather in Australia
4. Putting plants online: 4 leading botanical gardens to create first online catalog of all plants
5. EMBO welcomes 55 leading life scientists as members
6. Leading statistician receives national citation award
7. Leading childhood asthma group supports federal asthma action plan to reduce disparities
8. BiOptix Participates in Leading Life Sciences Event BioWest 2012
9. Team including UC Riverside entomologist honored for research leading to healthier potato chips
10. Aware Enables Automated Delivery of Radiation Dose Information Through Integration With Leading Radiology Reporting System
11. Discovery of pathway leading to depression reveals new drug targets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... -- Research and Markets has announced the addition of ... Industry Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft ... 8.8% over the next decade to reach approximately $14.21 billion by ... and forecasts for all the given segments on global as well ...
(Date:3/22/2017)... Optimove , provider of the ... as 1-800-Flowers and AdoreMe, today announced two new ... Using Optimove,s machine learning algorithms, these features allow ... recommendations to their customers based not just on ... intent drawn from a complex web of data ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela Merkel ... came to the DERMALOG stand together with the Japanese Prime Minster Shinzo ... At the largest German biometrics company the two government leaders could see ... as well as DERMALOG´s multi-biometrics system.   Continue ... ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... , March 28, 2017  The National Pharmaceutical Council ... the health policy research organization as its newest member. ... Regulatory Affairs ( North America ), will ... Directors. "We,re pleased to have Ipsen and ... Dan Leonard . "We welcome their insights in ...
(Date:3/28/2017)... WA (PRWEB) , ... March 28, 2017 , ... ... to announce the initial release of LabKey’s newest software solution, LabKey Biologics ... council of leading pharma and biotech organizations, LabKey Biologics provides drug research teams ...
(Date:3/28/2017)... -RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) ("RepliCel" ... clinical data from its phase 1/2 tendon repair study investigating ... (RCT-01) as a treatment for Achilles tendinosis. ... The clinical trial ... 6 months and showed no serious adverse events related to ...
(Date:3/27/2017)... ... March 27, 2017 , ... IsoPlexis ... against cancer, autoimmune disease and more through a single-cell precision engineering platform, today ... analysis platform developed in the laboratory of Dr. James Heath at the ...
Breaking Biology Technology: